Europe - July 6, 2026
New European initiative to accelerate drug discovery for cardiometabolic diseases
The Novo Nordisk Foundation is funding a new pan-European initiative to accelerate drug discovery and the development of next generation therapeutics for cardiometabolic diseases (CMDs).
Business article - June 29, 2026
“Our goal is to build a European framework that matches our scientific excellence with competitive financing capacity”
NLS asked Cedric Moreau, Chair of the Oversight Committee of the European Life Sciences Coalition (ELSC) and Partner at VC firm Sofinnova Partners, about the future of life sciences innovation and investment in Europe.
Business article - June 29, 2026
Open letter from ELSC calling on EU leaders to make life sciences a strategic priority
The newly formed European Life Sciences Coalition (ELSC) has sent an open letter to leading decision-makers and politicians in the EU and Sweden, urging them to take action.
Business article - June 29, 2026
In focus: Europe at a crossroads
Scientific excellence in a fragmented market means Europe will either lead or fall behind in global biotech.
Europe - May 27, 2026
Sartorius opens competence center for cell and gene therapy components in Germany
The new center in Freiburg is dedicated to the development and production of quality-critical materials for the cell and gene therapy market.
